Skip to content
Therapy But Better – Lifestyle
Author:
NovaBridge Biosciences
NovaBridge and Visara Announce Positive Results from VIS-101 Phase 2a Wet AMD Study
March 26, 2026
NovaBridge Announces Productive FDA Type B Meeting on Potential Accelerated Approval Pathway for Givastomig in Gastric Cancer
March 16, 2026
←
Previous Page
1
2